Document Top

  • All patient subgroups can benefit from Avastin

    Recommended infusion times for Avastin


        

     More

  • The established safety profile of Avastin

    Consistent benefit across tumour types

     

       

     More

  • Approved indications for Avastin

    Avastin plus conventional chemotherapy leads to superior efficacy

        

     More

  • Efficacy of Avastin in combination with a range of therapies

    Toxicity profiles do not generally overlap


        

     More

 

Patient cases

Physicians share their experience and discuss treatment options for patients with cancer.
The case presentations are designed to provide an insight into clinical practice and treatment decisions supported by trial data.

More

Educational webcasts

A series of webcasts highlighting some of the key learning points from scientific and clinical data.
Experienced physicians and scientists share their thoughts on the development of anticancer agents and discuss the options available for the treatment of cancer.

More

  • Expert perspective

    Expert perspective

    Importance of prolonging life (Prof Manuela Schmidinger)

    View

  • Angiogenesis, VEGF and the MoA of Avastin

    Angiogenesis, VEGF and the MoA of Avastin

    Precise VEGF inhibition with Avastin is a proven anti-tumour strategy

    View

  • Expert perspective

    Expert perspective

    Targeting angiogenesis (Prof Joaquin Bellmunt)

    View

Watch more

  • Role of continued anti-VEGF therapy

    Role of continued anti-VEGF therapy

    A summary of data supporting the use of Avastin until disease progression to achieve maximum benefit (Dr Mark Kozloff)

    View

  • Clinical endpoints in oncology

    Clinical endpoints in oncology

    A discussion of clinical trial endpoints used in oncology trials and how these translate into patient benefit (Dr Artur Katz)

    View

  • Inhibiting angiogenesis

    Inhibiting angiogenesis

    Inhibiting angiogenesis: a mechanistic evaluation (Prof Román Pérez‐Soler)

    View

Watch more

  • CRC patient case

    CRC patient case

    A patient with rectal adenocarcinoma and unresectable liver metastases (Prof Michel Ducreux)

    View

  • NSCLC patient case

    NSCLC patient case

    A patient who contacted her GP after experiencing pain in her lower right arm (Dr Martin Reck)

    View

  • mBC patient case

    mBC patient case

    A patient with triple-negative breast cancer (Dr Thierry Petit)

    View

Watch more

x

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.

OK Cancel